MariMed Inc. (MRMD): Price and Financial Metrics


MariMed Inc. (MRMD): $0.93

-0.03 (-3.14%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MRMD to Watchlist
Sign Up

Industry: Agriculture


Ranked

of 32

in industry

MRMD POWR Grades


  • Quality is the dimension where MRMD ranks best; there it ranks ahead of 82.42% of US stocks.
  • MRMD's strongest trending metric is Value; it's been moving up over the last 29 weeks.
  • MRMD ranks lowest in Momentum; there it ranks in the 16th percentile.

MRMD Stock Summary

  • With a year-over-year growth in debt of -49.35%, Marimed Inc's debt growth rate surpasses only 9.49% of about US stocks.
  • As for revenue growth, note that MRMD's revenue has grown 171.8% over the past 12 months; that beats the revenue growth of 95.83% of US companies in our set.
  • The volatility of Marimed Inc's share price is greater than that of 88.2% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Marimed Inc, a group of peers worth examining would be GDEN, STKS, DLHC, ARES, and OPRT.
  • MRMD's SEC filings can be seen here. And to visit Marimed Inc's official web site, go to marimedadvisors.com.

MRMD Valuation Summary

  • MRMD's price/sales ratio is 4; this is 11.11% higher than that of the median Healthcare stock.
  • MRMD's EV/EBIT ratio has moved up 16.8 over the prior 110 months.
  • Over the past 110 months, MRMD's price/earnings ratio has gone up 34.4.

Below are key valuation metrics over time for MRMD.

Stock Date P/S P/B P/E EV/EBIT
MRMD 2020-06-23 0.8 -5.4 -0.5 -1.2
MRMD 2020-03-04 1.1 0.6 23.5 5.5
MRMD 2018-12-17 63.2 17.2 -32.0 -34.5
MRMD 2018-10-31 104.7 40.2 -87.5 -97.4
MRMD 2016-06-28 7.1 -3.3 -1.1 -1.0
MRMD 2016-01-04 7.6 -3.6 -1.1 -1.1

MRMD Growth Metrics

  • The 2 year price growth rate now stands at -87.65%.
  • The 5 year cash and equivalents growth rate now stands at 393.67%.
  • Its 4 year net cashflow from operations growth rate is now at -2154.39%.
MRMD's revenue has moved up $90,399,759 over the prior 70 months.

The table below shows MRMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 91.03105 20.43225 17.49223
2021-03-31 68.0717 10.54679 8.785336
2020-12-31 50.89515 3.380303 2.143989
2020-09-30 35.73028 1.650395 -80.41652
2020-06-30 33.49248 -1.265987 -89.47407
2020-03-31 49.55485 -18.32119 -83.58295

MRMD Stock Price Chart Interactive Chart >

Price chart for MRMD

MRMD Price/Volume Stats

Current price $0.93 52-week high $1.20
Prev. close $0.96 52-week low $0.14
Day low $0.91 Volume 806,500
Day high $0.97 Avg. volume 1,283,550
50-day MA $0.93 Dividend yield N/A
200-day MA $0.82 Market Cap N/A

MariMed Inc. (MRMD) Company Bio


MariMed, Inc. engages in direct owning of cannabis licenses and management of seed-to-sale operations. It focuses on the development, operation, management, and optimization of facilities for the cultivation, production, and dispensing of medicinal and recreational cannabis and cannabis-infused products. The company was founded by Robert N. Fireman and Jon Levine on January 25, 2011 and is headquartered in Norwood, MA.


MRMD Latest News Stream


Event/Time News Detail
Loading, please wait...

MRMD Latest Social Stream


Loading social stream, please wait...

View Full MRMD Social Stream

Latest MRMD News From Around the Web

Below are the latest news stories about Marimed Inc that investors may wish to consider to help them evaluate MRMD as an investment opportunity.

3 Stocks to Buy Instead of SNDL or TLRY

With as many as 219 publicly traded marijuana companies out there, finding the ones worth investing in requires knowing what to look for.

Thomas Yeung on InvestorPlace | August 16, 2021

MariMed Reports Strong Second Quarter 2021 Earnings

MariMed, Inc. (OTCQX: MRMD) ("MariMed" or the "Company"), a leading multi-state cannabis operator focused on health and wellness and improving lives every day, today announced its financial and operating results for the quarter ended June 30, 2021.

Yahoo | August 16, 2021

MariMed Adds Key Executives to its Team To Drive Revenue and Build Brand Value

Former Sam Adams CMO Robert Hall to Serve as Senior Brand and Marketing Advisor Kevin Compagna Joins MariMed as VP, Wholesale & Licensing for North America NORWOOD, Mass., Aug. 10, 2021 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD:OTCQX) (the "Company" or "MariMed"), a leading multi-state cannabis operator focused on health and wellness, today announced a series of appointments intended to help the company drive sales of its award-winning brand portfolio. Senior CPG marketer and former Sam Adams beer

Yahoo | August 10, 2021

We All Scream For Cannabis Ice-Cream: MariMed, Emack & Bolio Team Up To Create Weed Gelato

MariMed (OTCQX: MRMD) recently partnered with Massachusetts-based ice cream brand Emack & Bolio’s to develop of a new cannabis-infused ice cream brand. Together, they will create a line-up of cannabis-infused vegan and dairy ice cream. The ice cream will contain the same whole-plant cannabinoid and terpene formulations found in MariMed’s brands, such as Betty’s Eddies and K Fusion. “MariMed and Emack & Bolio’s are aligned in our craft-like approach to product development, which is why I'm excite

Yahoo | August 9, 2021

MariMed and Legendary Emack & Bolio’s Brand Collaborate To Create New Brand of Cannabis Infused Ice Cream

NORWOOD, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) ("MariMed" or the "Company"), a leading multi-state cannabis operator focused on health and wellness, today announced a joint collaboration with the legendary Boston ice cream brand Emack & Bolio’s®.MariMed and the ice cream magicians at Emack & Bolio’s will create a line-up of cannabis-infused vegan and dairy ice cream in outrageous flavors. The ice cream will contain MariMed’s superior formulations that include the s

Yahoo | August 5, 2021

Read More 'MRMD' Stories Here

MRMD Price Returns

1-mo -2.64%
3-mo -1.43%
6-mo 20.47%
1-year 490.48%
3-year -75.20%
5-year N/A
YTD 97.87%
2020 -23.92%
2019 -80.99%
2018 371.01%
2017 193.62%
2016 56.67%

Continue Researching MRMD

Here are a few links from around the web to help you further your research on Marimed Inc's stock as an investment opportunity:

Marimed Inc (MRMD) Stock Price | Nasdaq
Marimed Inc (MRMD) Stock Quote, History and News - Yahoo Finance
Marimed Inc (MRMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8021 seconds.